alanylproline has been researched along with isoleucyl-tyrosine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, F; Huo, J; Jin, H; Wang, W; Wang, Y; Wang, Z; Zhang, L; Zhang, S; Zhou, L | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
He, Z; Li, T; Lu, D; Qi, W; Su, R; Wu, S | 1 |
3 other study(ies) available for alanylproline and isoleucyl-tyrosine
Article | Year |
---|---|
Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Databases, Factual; Humans; Hydrogen Bonding; Hypertension; Male; Models, Chemical; Models, Molecular; Peptides; Peptidyl-Dipeptidase A; Quantitative Structure-Activity Relationship; Software; Solutions; Testis | 2011 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.
Topics: Algorithms; Angiotensin-Converting Enzyme Inhibitors; Anti-Infective Agents; Models, Molecular; Peptides; Quantitative Structure-Activity Relationship; Regression Analysis; Taste | 2014 |